243 related articles for article (PubMed ID: 23360496)
1. Follicular thyroid cancer incidence patterns in the United States, 1980-2009.
Aschebrook-Kilfoy B; Grogan RH; Ward MH; Kaplan E; Devesa SS
Thyroid; 2013 Aug; 23(8):1015-21. PubMed ID: 23360496
[TBL] [Abstract][Full Text] [Related]
2. Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008.
Veiga LH; Neta G; Aschebrook-Kilfoy B; Ron E; Devesa SS
Thyroid; 2013 Jun; 23(6):748-57. PubMed ID: 23410185
[TBL] [Abstract][Full Text] [Related]
3. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.
Aschebrook-Kilfoy B; Ward MH; Sabra MM; Devesa SS
Thyroid; 2011 Feb; 21(2):125-34. PubMed ID: 21186939
[TBL] [Abstract][Full Text] [Related]
4. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005.
Enewold L; Zhu K; Ron E; Marrogi AJ; Stojadinovic A; Peoples GE; Devesa SS
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):784-91. PubMed ID: 19240234
[TBL] [Abstract][Full Text] [Related]
5. Incidence of papillary thyroid cancer: Comparison of the military and the general population by race and tumor stage/size.
Bytnar JA; Enewold L; Shriver CD; Zhu K
Cancer Epidemiol; 2024 Apr; 89():102539. PubMed ID: 38340498
[TBL] [Abstract][Full Text] [Related]
6. Racial/ethnic differences in thyroid cancer incidence in the United States, 2007-2014.
Weeks KS; Kahl AR; Lynch CF; Charlton ME
Cancer; 2018 Apr; 124(7):1483-1491. PubMed ID: 29338082
[TBL] [Abstract][Full Text] [Related]
7. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.
Chen AY; Jemal A; Ward EM
Cancer; 2009 Aug; 115(16):3801-7. PubMed ID: 19598221
[TBL] [Abstract][Full Text] [Related]
8. Thyroid cancer incidence among active duty U.S. military personnel, 1990-2004.
Enewold LR; Zhou J; Devesa SS; Berrington de Gonzalez A; Anderson WF; Zahm SH; Stojadinovic A; Peoples GE; Marrogi AJ; Potter JF; McGlynn KA; Zhu K
Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2369-76. PubMed ID: 21914838
[TBL] [Abstract][Full Text] [Related]
9. A Bedside Risk Calculator to Preoperatively Distinguish Follicular Thyroid Carcinoma from Follicular Variant of Papillary Thyroid Carcinoma.
Englum BR; Pura J; Reed SD; Roman SA; Sosa JA; Scheri RP
World J Surg; 2015 Dec; 39(12):2928-34. PubMed ID: 26324158
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities of differentiated thyroid carcinoma: clinical behavior, treatments, and long-term outcomes.
Tang J; Kong D; Cui Q; Wang K; Zhang D; Liao X; Gong Y; Wu G
World J Surg Oncol; 2018 Mar; 16(1):45. PubMed ID: 29506526
[TBL] [Abstract][Full Text] [Related]
11. Geospatial and Temporal Analysis of Thyroid Cancer Incidence in a Rural Population.
Hanley JP; Jackson E; Morrissey LA; Rizzo DM; Sprague BL; Sarkar IN; Carr FE
Thyroid; 2015 Jul; 25(7):812-22. PubMed ID: 25936441
[TBL] [Abstract][Full Text] [Related]
12. The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States.
Aschebrook-Kilfoy B; Kaplan EL; Chiu BC; Angelos P; Grogan RH
Ann Surg Oncol; 2013 Aug; 20(8):2746-53. PubMed ID: 23504142
[TBL] [Abstract][Full Text] [Related]
13. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland.
Kilfoy BA; Devesa SS; Ward MH; Zhang Y; Rosenberg PS; Holford TR; Anderson WF
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1092-100. PubMed ID: 19293311
[TBL] [Abstract][Full Text] [Related]
14. Thyroid Cancer Incidence Trends in the United States: Association with Changes in Professional Guideline Recommendations.
Pereira M; Williams VL; Hallanger Johnson J; Valderrabano P
Thyroid; 2020 Aug; 30(8):1132-1140. PubMed ID: 32098591
[No Abstract] [Full Text] [Related]
15. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
Lim H; Devesa SS; Sosa JA; Check D; Kitahara CM
JAMA; 2017 Apr; 317(13):1338-1348. PubMed ID: 28362912
[TBL] [Abstract][Full Text] [Related]
16. Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary, follicular, and anaplastic: a morphological and epidemiological study.
Albores-Saavedra J; Henson DE; Glazer E; Schwartz AM
Endocr Pathol; 2007; 18(1):1-7. PubMed ID: 17652794
[TBL] [Abstract][Full Text] [Related]
17. Increasing incidence of thyroid cancer in the United States, 1973-2002.
Davies L; Welch HG
JAMA; 2006 May; 295(18):2164-7. PubMed ID: 16684987
[TBL] [Abstract][Full Text] [Related]
18. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns].
Hundahl SA; Fleming ID; Fremgen AM; Menck HR
Cancer; 1998 Dec; 83(12):2638-48. PubMed ID: 9874472
[TBL] [Abstract][Full Text] [Related]
19. Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993-2013.
Milano AF
J Insur Med; 2018 Jan; 47(3):143-158. PubMed ID: 30192723
[TBL] [Abstract][Full Text] [Related]
20. Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011.
O'Grady TJ; Gates MA; Boscoe FP
Int J Cancer; 2015 Dec; 137(11):2664-73. PubMed ID: 26069163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
